Research programme: stroke therapies - CereMedix
Alternative Names: CMX-21169; CMX-9236Latest Information Update: 12 Jul 2007
At a glance
- Originator CereMedix
- Class
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stroke
Most Recent Events
- 27 Jul 2004 Preclinical trials in Stroke in USA (unspecified route)